PRTA · Categories · Form 4

PRTA - SEC Form 4 insider transactions

Prothena Corporation plc (PRTA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PRTA

• 24d
  SEC Form 4 filed by Director Welch Daniel G

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 24d
  SEC Form 4 filed by Director Selkoe Dennis J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 24d
  SEC Form 4 filed by Director Ekman Lars

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 24d
  SEC Form 4 filed by Director Dunn William H. Jr.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 24d
  SEC Form 4 filed by Director Cooke Shane

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 24d
  SEC Form 4 filed by Director Collier Richard T

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 59d
  SEC Form 4 filed by Kingston Anne Evans

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Scientific Officer Zago Wagner M.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Accounting Officer Walker Karin L

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Development Officer Swanson Chad J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Operating Officer Smith Brandon S.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Strategy Officer and CFO Nguyen Tran

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by Chief Legal Officer Malecek Michael J

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 95d
  SEC Form 4 filed by President and CEO Kinney Gene G.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Scientific Officer Zago Wagner M. was granted 85,000 units of Ordinary Shares (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Accounting Officer Walker Karin L was granted 25,000 units of Ordinary Shares (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Development Officer Swanson Chad J. was granted 85,000 units of Ordinary Shares (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Operating Officer Smith Brandon S. was granted 130,000 units of Ordinary Shares (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Strategy Officer and CFO Nguyen Tran was granted 95,000 units of Ordinary Shares, increasing direct ownership by 4,308% to 97,205 units (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  Chief Legal Officer Malecek Michael J was granted 80,000 units of Ordinary Shares (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 313d
  President and CEO Kinney Gene G. was granted 140,000 units of Ordinary Shares, increasing direct ownership by 1,094% to 152,793 units (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Welch Daniel G

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Selkoe Dennis J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Kim Helen Susan

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Ekman Lars

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Dunn William H. Jr.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Cooke Shane

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Collier Richard T

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 388d
  SEC Form 4 filed by Director Cobb Paula K

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 398d
  Large owner Ecor1 Capital, Llc sold $50,839,807 worth of Ordinary Shares (6,279,684 units at $8.10) (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Scientific Officer Zago Wagner M.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Accounting Officer Walker Karin L

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Development Officer Swanson Chad J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Operating Officer Smith Brandon S.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Strategy Officer and CFO Nguyen Tran

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Legal Officer Malecek Michael J

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by President and CEO Kinney Gene G.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief Regulatory Officer Karp Carol D.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 458d
  SEC Form 4 filed by Chief People Officer Ford David A

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 479d
  Chief Strategy Officer and CFO Nguyen Tran disposed of 995 units of Ordinary Shares, decreasing direct ownership by 31% to 2,205 units (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 613d
  SEC Form 4 filed by Chief Development Officer Swanson Chad J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Welch Daniel G

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Selkoe Dennis J.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Kim Helen Susan

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Ekman Lars

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Dunn William H. Jr.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Cooke Shane

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Collier Richard T

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 752d
  SEC Form 4 filed by Cobb Paula K

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 825d
  SEC Form 4 filed by Ford David A

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Zago Wagner M.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Walker Karin L

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Smith Brandon S.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Nguyen Tran

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Malecek Michael J

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Kinney Gene G.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Karp Carol D.

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 830d
  SEC Form 4 filed by Garren Hideki

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 836d
  SEC Form 4 filed by Welch Daniel G

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)
• 866d
  Walker Karin L exercised 5,000 units of Ordinary Shares at a strike of $13.53 and sold $170,000 worth of Ordinary Shares (5,000 units at $34.00) (SEC Form 4)

  4 - PROTHENA CORP PUBLIC LTD CO (0001559053) (Issuer)

Other PRTA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends